Pronounced “soh-TIK-too,” SOTYKTU is a once-daily pill for adults with moderate to severe plaque psoriasis that works inside ...

There are several types of rosacea, which can cause different symptoms. You might have one or more of these types.

A total of 432 patients (56.3% women) aged 12 and older with psoriasis on the scalp and body were randomly assigned to two groups, one of which used roflumilast foam 0.3% once a day for eight ...

Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase III trial. Improvements in scalp itch were also greater for patients ...

Results showed 66% of patients treated with icotrokinra achieved an ss-IGA score of 0/1 and 77% achieved a sPGA-G score of 0/1, compared with 11% and 21% receiving placebo, respectively, at week 16.

Psoriasis significantly impacts psychological and social well-being, with high rates of depression, anxiety, and suicidal ideation among patients. Effective management requires a holistic, patient ...

A bride-to-be on the quest to look picture perfect on her big day had surgery to remove saggy skin from her eyelids costing $1.5k and says it was “worth every penny” Self-conscious Kayley ...

Neither oats nor green smoothie: this forgotten breakfast is the best for the gut, according to experts It is likely that at some point you have felt that your upper eyelid twitches. This is not ...

If you're looking for a safe, affordable, and natural way to get rid of skin tags at home, Revita g is one of the best skin ...

Once-daily 0.3% topical roflumilast foam significantly reduced severity in patients with psoriasis of the scalp and body over 8 weeks, with a favorable safety profile. “Use of roflumilast foam ...

In 2022, a drug called deucravacitinib was approved by the U.S. Food and Drug Administration to treat psoriasis. This medication targets TYK2 in a way that stops its ability to relay harmful ...